10 Best High-Margin Pharma Stocks to Buy Now

Page 9 of 9

1. Novo Nordisk A/S (NYSE:NVO)

TTM Operating Profit Margin: 48.43%

Average Analyst upside: 45,64%

Number of Hedge Fund Holders: 60

Novo Nordisk A/S (NYSE:NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on Novo Nordisk A/S (NYSE:NVO), maintaining a price target of 610 Danish kroner, equivalent to roughly $88 per American Depositary Receipt (ADR), as investors await clarity on U.S. prescription trends for the company’s blockbuster weight-loss drug, Wegovy.

The firm is taking a measured stance ahead of Novo Nordisk’s second-quarter earnings report, scheduled for August 6. Analysts are focused on whether the recent wind-down of compounded semaglutide (the active ingredient in Ozempic and Wegovy) products in the U.S. has translated into stronger volume growth for Wegovy. So far, prescription trends appear to have plateaued quarter-over-quarter, raising questions about underlying demand momentum.

Attention is also centered on the implications of Novo Nordisk’s new pharmacy benefit partnership with CVS Caremark, which may influence pricing dynamics and reimbursement access. Analysts believe the company could revise its 2025 sales guidance, particularly if Wegovy uptake remains flat through the current quarter.

Berenberg’s cautious tone reflects broader market concerns around valuation and future growth visibility, even as Novo Nordisk continues to lead in the GLP-1 obesity treatment space. While long-term prospects for Wegovy and other pipeline assets remain strong, investors appear to be seeking more definitive signs of sustained prescription acceleration in the U.S. before re-rating the stock more aggressively.

While we acknowledge the risk and potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9